{"gene":"SIX2","run_date":"2026-06-10T07:46:32","timeline":{"discoveries":[{"year":2008,"finding":"Six2-expressing cap mesenchyme cells are a multipotent nephron progenitor population that self-renew throughout kidney development. Six2 functions cell-autonomously to maintain progenitor status: cap mesenchyme cells lacking Six2 activity ectopically contribute to nephron tubules via a Wnt9b inductive signal, demonstrating Six2's cell-autonomous role in suppressing differentiation.","method":"Genetic lineage tracing (pulse labeling), clonal analysis, conditional loss-of-function, organ culture","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal genetic methods (lineage tracing, clonal analysis, conditional KO) replicated across developmental stages; mechanistic epistasis with Wnt9b established","pmids":["18682239"],"is_preprint":false},{"year":2006,"finding":"Six2 is required to maintain the metanephric mesenchyme progenitor population in an undifferentiated state by opposing inductive signals from the ureteric bud. Functional inactivation of Six2 causes premature and ectopic mesenchymal-to-epithelial differentiation and depletion of progenitors. Gain of Six2 function in cortical mesenchymal cells is sufficient to prevent their epithelial differentiation.","method":"Loss-of-function mouse genetics (Six2 knockout), gain-of-function in organ culture assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal loss- and gain-of-function experiments with defined cellular phenotype, independently replicated","pmids":["17036046"],"is_preprint":false},{"year":2012,"finding":"Six2 and β-catenin (Wnt signaling) co-occupy shared cis-regulatory modules flanking Wnt4 and Fgf8 in nephron progenitors. Six2 and Lef/Tcf factors form a regulatory complex that promotes progenitor maintenance, while entry of β-catenin into this complex promotes nephrogenesis. This regulatory balance controls commitment vs. self-renewal.","method":"Chromatin immunoprecipitation (ChIP), transcriptional profiling, in vitro and in vivo reporter assays, mutagenesis of Lef/Tcf binding sites","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — ChIP, transcriptional profiling, cis-regulatory mutagenesis, and in vivo validation; multiple orthogonal methods in single study","pmids":["22902740"],"is_preprint":false},{"year":2014,"finding":"Eya1 interacts with Six2 (and Myc) to control self-renewing nephron progenitor cell activity. Six2 mediates translocation of Eya1 to the nucleus, where Eya1 uses its threonine phosphatase activity to control Myc phosphorylation/dephosphorylation. Conditional inactivation of Eya1 leads to loss of Six2 expression and premature epithelialization of progenitors.","method":"Co-immunoprecipitation, conditional knockout, cell fate tracing, biochemical phosphatase assay","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, conditional KO with defined phenotype, biochemical phosphatase assay; multiple orthogonal methods","pmids":["25458011"],"is_preprint":false},{"year":2004,"finding":"Six2 activates expression of the Gdnf gene by binding to two Six2 binding sites in the Gdnf promoter. Six2 also binds and activates its own promoter (autoregulation). Six2 possesses a transcriptional activation domain in the C-terminus and nuclear localization determinants in the Six domain.","method":"Promoter-reporter assay, DNA binding assay (identification of promoter binding sites), transgenic LacZ reporter mice, biochemical characterization of Six2 protein domains","journal":"Mechanisms of development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assays with identified binding sites and domain mapping; single lab, two orthogonal methods","pmids":["15327782"],"is_preprint":false},{"year":2014,"finding":"Osr1 acts downstream of Six2 (Six2 is required to maintain Osr1 expression in undifferentiated cap mesenchyme) and both act synergistically to prevent premature nephron progenitor differentiation. Osr1, but not Six2, enhances TCF interaction with Groucho co-repressors to antagonize Wnt/β-catenin-directed nephrogenic differentiation.","method":"Conditional knockout (tissue-specific), epistasis analysis, protein interaction assay (TCF-Groucho complex), in vivo Wnt4 enhancer reporter","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with defined phenotype, epistasis between Six2 and Osr1, protein interaction (TCF-Groucho), in vivo reporter; multiple orthogonal methods","pmids":["24598167"],"is_preprint":false},{"year":2009,"finding":"A single enhancer site upstream of the Six2 coding sequence is responsible for both activation by Hox11 proteins in the kidney and repression by Hoxa2 in the branchial arch and facial mesenchyme. DNA-binding activity is required for both activation and repression, but protein domains N- and C-terminal to the homeodomain confer activation versus repression activity.","method":"In vivo enhancer analysis in transgenic mice, mutagenesis of Hox protein domains, loss-of-function genetics","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vivo enhancer dissection with domain mutagenesis, both activation and repression mechanisms established in single study","pmids":["19716816"],"is_preprint":false},{"year":2008,"finding":"Six2 is a direct downstream transcriptional target of Hoxa2 in vivo. Ectopic expression of Six2 in the absence of Hoxa2 contributes to the Hoxa2 mouse mutant phenotype, and Six2 acts to mediate Hoxa2 control over the insulin-like growth factor pathway during branchial arch development.","method":"Genetic epistasis, in vivo target gene identification, loss-of-function (Hoxa2 knockout)","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis in vivo, direct downstream target demonstrated with rescue experiments","pmids":["18321982"],"is_preprint":false},{"year":2016,"finding":"Notch signaling is necessary and sufficient for downregulation of Six2 during nephrogenesis. Loss of Notch signaling in nephron progenitors prevents Six2 downregulation and blocks differentiation into any nephron segment, placing Notch upstream of Six2 in the differentiation pathway.","method":"Conditional gain- and loss-of-function of Notch signaling in mice, analysis of Six2 expression","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal gain/loss-of-function, defined cellular phenotype, pathway epistasis established","pmids":["27633993"],"is_preprint":false},{"year":2014,"finding":"Six2 promotes breast cancer metastasis by transcriptionally and epigenetically repressing E-cadherin. Mechanistically, Six2 upregulates Zeb2 (in part through a microRNA-mediated mechanism) and stimulates promoter methylation of the E-cadherin gene (Cdh1). E-cadherin downregulation is necessary for Six2's ability to increase soft agar growth and in vivo metastasis.","method":"Loss-of-function (knockdown), gain-of-function (overexpression), in vivo metastasis assay, promoter methylation analysis, epistasis rescue","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo metastasis model, promoter methylation, epistasis; single lab with multiple orthogonal methods","pmids":["25348955"],"is_preprint":false},{"year":2019,"finding":"Six2 directly binds the Sox2 Srr2 enhancer, promoting Sox2 expression and downstream expression of Nanog in breast cancer cells, thereby enhancing cancer stem cell properties and metastatic colonization.","method":"ChIP (direct enhancer binding), knockdown/overexpression functional assays, in vivo metastasis models","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct binding, multiple functional assays; single lab","pmids":["30606720"],"is_preprint":false},{"year":2021,"finding":"Eya1 and Six2 interact with the Brg1-based SWI/SNF chromatin remodeling complex during kidney development. Brg1 occupies a distal enhancer of Eya1 driving nephron progenitor-specific expression. Brg1 enrichment to distal intronic enhancers of Pbx1 and a proximal promoter of Mycn requires Six2 activity.","method":"Co-immunoprecipitation (tagged knock-in), conditional knockout, genome-wide ChIP-seq, transcriptome profiling, in vivo enhancer reporter assay","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP with tagged knock-in, genome-wide binding analysis, conditional KO with transcriptome profiling, in vivo reporters; multiple orthogonal methods","pmids":["34716243"],"is_preprint":false},{"year":2020,"finding":"SIX2 regulates functional maturation of human SC-β cells; knockdown or knockout of SIX2 drastically limits glucose-stimulated insulin secretion, cytoplasmic calcium flux, and mitochondrial respiration, and regulates expression of genes associated with these β cell processes.","method":"Knockdown (KD) and knockout (KO) in hESC-derived β cells, static and dynamic insulin secretion assays, calcium imaging, mitochondrial respiration assay, transcriptome analysis","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD and KO with multiple functional readouts; single lab, orthogonal assays","pmids":["32460030"],"is_preprint":false},{"year":2021,"finding":"SIX2 and SIX3 regulate distinct gene targets in human β cells: SIX2 loss markedly impairs expression of genes governing β-cell insulin processing, glucose sensing, and electrophysiology. Chromatin accessibility studies identified genes directly regulated by SIX2.","method":"shRNA knockdown in human adult islets, transcriptome analysis, chromatin accessibility (ATAC-seq)","journal":"Genes & development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — shRNA in native human islets, transcriptome + chromatin accessibility; single lab, two orthogonal methods","pmids":["33446570"],"is_preprint":false},{"year":2019,"finding":"Six2 mediates the neuroprotective effect of GDNF on dopaminergic neurons by directly binding to the CAGCTG sequence of the Smurf1 promoter and promoting Smurf1 expression, which in turn decreases p53 expression to reduce apoptosis.","method":"ChIP-seq, ChIP-qPCR, knockdown/overexpression, in vitro and in vivo apoptosis assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq for genome-wide binding plus ChIP-qPCR validation, functional rescue; single lab","pmids":["27148690"],"is_preprint":false},{"year":2019,"finding":"Six2 activates the GDNF promoter by directly binding to it in dopaminergic cells, and this activation is regulated by the Akt1/Eya1/Six2 signaling axis: Akt1 phosphorylates Eya1, activated Eya1 decreases Six2 phosphorylation, and dephosphorylated Six2 promotes GDNF transcription.","method":"ChIP-qPCR (direct promoter binding), phosphorylation analysis, knockdown/overexpression","journal":"Journal of molecular neuroscience : MN","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-qPCR for direct binding, kinase cascade analysis; single lab, two orthogonal methods","pmids":["31720997"],"is_preprint":false},{"year":2015,"finding":"LIF activates STAT, which binds to a STAT consensus sequence in the Six2 proximal promoter to sustain SIX2 levels in metanephric mesenchyme cells, maintaining the SIX2+ progenitor pool.","method":"Promoter-reporter assay, STAT binding site identification, LIF stimulation experiments, in vitro culture model","journal":"Stem cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — STAT binding site in Six2 promoter identified and functionally tested; single lab","pmids":["26321142"],"is_preprint":false},{"year":2019,"finding":"Six2 directly binds to the PAX9 5' upstream regulatory element and activates PAX9 expression; a human SIX2 coding missense variant (p.Gly264Glu) affects SIX2 protein stability and leads to decreased PAX9 expression.","method":"ChIP (SIX2 binding to PAX9 enhancer), luciferase reporter assay, mutagenesis (variant functional analysis), protein stability assay","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP binding, reporter assay, variant functional analysis; single lab, two orthogonal methods","pmids":["31765609"],"is_preprint":false},{"year":2017,"finding":"In the developing kidney, Six2-dependent progenitor proliferation and self-renewal are separable by gene dosage: Six2 heterozygotes show increased nephron progenitor proliferation with increased MYC protein and MYC target gene upregulation, despite reduced SIX2 levels.","method":"Quantitative morphometry, EdU labeling (proliferation), immunostaining (MYC protein), transcriptional profiling","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative proliferation assay, molecular marker analysis; single lab, multiple readouts","pmids":["29217079"],"is_preprint":false},{"year":2009,"finding":"Six2 activity is required for the formation of the pyloric sphincter, regulating a gene network including Bmp4, Bmpr1b, Nkx2.5, Sox9, and Gremlin in mice.","method":"Loss-of-function genetics (Six2 null mice), expression analysis of target genes","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined phenotype in KO mouse, expression of downstream genes; single lab","pmids":["19660448"],"is_preprint":false},{"year":2021,"finding":"Smarcd1 (a SWI/SNF chromatin-remodeling complex member) forms a transcription complex with Six2 in dopaminergic neurons and is recruited to the GDNF promoter (specifically the 2840–2933 bp region) by Six2 to enhance Six2-driven GDNF expression and protect against apoptosis.","method":"Co-immunoprecipitation, ChIP (Smarcd1 binding to GDNF promoter region), knockdown/overexpression functional assays, LC-ESI-MS (interactome screen)","journal":"Neuroscience letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and ChIP for direct complex and promoter binding; single lab, two orthogonal methods","pmids":["34233203"],"is_preprint":false},{"year":2017,"finding":"Six2 functions downstream of Hoxa2 in palate development: Six2 mRNA and protein are upregulated in Hoxa2-null palatal shelves, and siRNA-mediated Six2 knockdown restores proliferation and Cyclin D1 expression in Hoxa2-null palatal mesenchyme cells to near wild-type levels.","method":"Conditional loss-of-function (Hoxa2 KO), siRNA knockdown, cell proliferation assay (Ki-67 immunostaining, in vitro proliferation), western blot","journal":"Frontiers in physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis between Hoxa2 and Six2 confirmed by siRNA rescue; single lab, two orthogonal methods","pmids":["29218017"],"is_preprint":false},{"year":2018,"finding":"In Lowe syndrome (OCRL1 mutation), the transcription factor Six2 is substantially retained in the Golgi complex in kidney-differentiated cells, with reduced nuclear-localized fraction; OCRL1 knockout reproduces both ciliogenesis defects and Six2 retention at the Golgi.","method":"iPSC differentiation to kidney cells, immunofluorescence (subcellular fractionation/localization), OCRL1 KO in HK2 cells","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct subcellular localization with functional consequence (reduced nuclear fraction); confirmed in multiple cell systems","pmids":["29444177"],"is_preprint":false},{"year":2024,"finding":"SIX2 depletion in androgen-independent prostate cancer cells induces a switch from stem-like to epithelial state, reducing proliferation, colony formation, and metastasis both in vitro and in vivo. These effects are mediated through downregulation of the Wnt/β-catenin signaling pathway and reduction of nuclear β-catenin.","method":"Knockdown (siRNA/shRNA), chromatin accessibility analysis, in vitro and in vivo functional assays, immunostaining for nuclear β-catenin","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD with defined phenotype in vitro and in vivo, chromatin landscape analysis; single lab, multiple orthogonal methods","pmids":["38554106"],"is_preprint":false},{"year":2024,"finding":"SIX2 directly regulates METTL9 expression (shown by CUT&Tag analysis). METTL9 binds to SLC7A11 (confirmed by Co-IP), enhancing SLC7A11 stability and reducing degradation, thereby regulating ferroptosis independently of the GPX4 pathway.","method":"CUT&Tag (direct binding), Co-immunoprecipitation (METTL9-SLC7A11 interaction), RNA sequencing, overexpression/knockdown functional assays","journal":"NPJ precision oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CUT&Tag for direct binding, Co-IP for protein interaction; single lab, two orthogonal methods","pmids":["40523929"],"is_preprint":false},{"year":2025,"finding":"TRIM21 acts as an E3 ubiquitin ligase for SIX2: TRIM21 binds to SIX2 via its PRY-SPRY domain and catalyzes K48-type ubiquitination at lysine residues K82, K89, and K97 of SIX2, promoting its degradation via the ubiquitin-proteasome pathway. SIX2 transcriptionally activates LGSN expression through direct binding to its promoter.","method":"Co-immunoprecipitation, ubiquitination assay (K48-type), site-directed mutagenesis (K82/K89/K97), ChIP (SIX2 binding to LGSN promoter), proteasome inhibition (MG132)","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — Co-IP, site-directed mutagenesis of ubiquitination sites, ChIP for direct promoter binding; single lab with multiple orthogonal methods","pmids":["40954199"],"is_preprint":false},{"year":2023,"finding":"NIK (NF-κB Inducing Kinase) promotes SIX2 protein stability by suppressing its ubiquitination via the ubiquitin-proteasome system: NIK knockdown promotes SIX2 ubiquitination and decreases its protein stability (rescued by MG132 proteasome inhibitor), without affecting SIX2 mRNA levels.","method":"Knockdown, ubiquitination assay, MG132 proteasome inhibitor rescue, protein stability assay","journal":"Environmental toxicology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ubiquitination assay, proteasome inhibitor rescue; single lab, two orthogonal methods","pmids":["37461228"],"is_preprint":false},{"year":2024,"finding":"SIX2 directly binds the PFN2 promoter to activate PFN2 expression. In turn, PFN2 promotes mRNA stability of SIX2 by recruiting the RNA binding protein YBX-1, activating the MAPK/JNK pathway downstream.","method":"ChIP (SIX2 binding to PFN2 promoter), RNA stability assay, Co-immunoprecipitation (PFN2-YBX-1), JNK pathway inhibition","journal":"Journal of translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP, RNA stability assay, Co-IP; single lab, multiple orthogonal methods","pmids":["39256760"],"is_preprint":false},{"year":2024,"finding":"Aberrant enhancer-promoter interactions in the Six2TGC transgene drive ectopic expression of Six3 (not Six2), which interferes with SIX2 function in nephron progenitor cell renewal through its C-terminal domain, causing reduced nephron endowment.","method":"Targeted locus amplification (integration site mapping), Hi-C (chromatin conformation capture), CRISPR disruption of Six3 within transgene, genetic rescue experiments","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — Hi-C chromatin conformation, CRISPR disruption with rescue, multiple genetic approaches in single study","pmids":["38447671"],"is_preprint":false},{"year":2019,"finding":"DNMT1 is required in Six2-positive nephron progenitor cells for silencing of transposable elements and embryonic non-renal lineage genes; loss of DNMT1 (but not DNMT3a, DNMT3b, or TET2) in Six2-positive cells leads to severe kidney developmental defects with endogenous retroviral transcript activation and cell death.","method":"Conditional knockout (Six2-Cre driver), genome-wide methylation analysis (WGBS), RNA-seq, comparison with DNMT3a/3b/TET2 conditional KOs","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with genome-wide molecular profiling and systematic comparison among multiple epigenetic enzymes; single lab but comprehensive","pmids":["30850438"],"is_preprint":false},{"year":2017,"finding":"Six2 marks a dynamic subset of second heart field progenitors whose descendants are allocated successively to regions of the heart. Six2 expression in cardiac progenitors depends in part on Shh signaling, and Shh deletion results in severe deficiency of Six2-positive progenitors.","method":"Genetic lineage tracing, progenitor ablation, conditional knockout of Shh, immunostaining","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — lineage tracing and genetic ablation with defined phenotype; single lab","pmids":["28122228"],"is_preprint":false},{"year":2022,"finding":"Six1 cannot substitute for Six2 in mouse nephron progenitor renewal: forced Six1 expression mediated Eya1 nuclear translocation and inhibited premature epithelialization, but failed to rescue proliferation defects and cell death caused by Six2 knockout. Genome-wide binding showed Six1 occupied only a subset of Six2 target sites, with many Six2-bound loci crucial to progenitor renewal lacking Six1 occupancy.","method":"Conditional knock-in (Six1 replacing Six2), genome-wide ChIP-seq (Six1 vs. Six2 binding), phenotypic rescue analysis","journal":"Frontiers in cell and developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide binding comparison, conditional knock-in rescue experiment; single lab with multiple orthogonal methods","pmids":["35178390"],"is_preprint":false},{"year":2017,"finding":"Smad3 can transcriptionally target Six2 (identified by bioinformatics and validated by luciferase assay). TβRII promotes Six2 expression through Smad3-mediated transcriptional regulation; Six2 partially rescues proliferation defects caused by TβRII knockdown in metanephric mesenchyme cells.","method":"Luciferase reporter assay (Smad3 targeting Six2 promoter), knockdown/overexpression, EdU proliferation assay","journal":"International journal of molecular sciences","confidence":"Low","confidence_rationale":"Tier 3 / Weak — luciferase assay and functional rescue; single lab, limited orthogonal validation","pmids":["28420207"],"is_preprint":false},{"year":2016,"finding":"Zeb1 promotes Six2 promoter reporter activity (luciferase assay) and its expression in metanephric mesenchyme cells; knockdown of Zeb1 decreases Six2 expression and reduces cell proliferation and migration.","method":"Dual-luciferase reporter assay, knockdown, western blot, RT-PCR, EdU assay","journal":"International journal of molecular sciences","confidence":"Low","confidence_rationale":"Tier 3 / Weak — luciferase assay plus expression analysis; single lab, single method for transcriptional regulation","pmids":["27509493"],"is_preprint":false},{"year":2017,"finding":"GATA1 directly binds the Six2 promoter and promotes its transcriptional activity; mutation of GATA1 binding sites in the mSix2 promoter decreases promoter activity. Knockdown of GATA1 reduces Six2 expression and increases apoptosis in metanephric mesenchyme cells, which is rescued by Six2 overexpression.","method":"Luciferase reporter assay with GATA1 binding site mutagenesis, knockdown, qPCR, apoptosis assay, rescue experiment","journal":"In vitro cellular & developmental biology. Animal","confidence":"Low","confidence_rationale":"Tier 3 / Weak — luciferase assay with site mutagenesis, functional rescue; single lab","pmids":["28842839"],"is_preprint":false},{"year":2024,"finding":"TRIM25 directly interacts with SIX2 and promotes its ubiquitination and degradation; TRIM25 reduces SPRED2 transcription (via SIX2 degradation), leading to ERK phosphorylation and suppression of neuronal autophagy under high-glucose conditions. SIX2 transcriptionally activates SPRED2 expression.","method":"Co-immunoprecipitation, cycloheximide chase assay, ubiquitination assay, ChIP, dual-luciferase reporter, western blot","journal":"Journal of molecular neuroscience : MN","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ubiquitination assay, protein stability assay, ChIP; single lab, multiple orthogonal methods","pmids":["42105075"],"is_preprint":false},{"year":2026,"finding":"EYA4 interacts with SIX2 to promote p21 expression and accelerate cellular senescence. This regulatory function is independent of EYA4's phosphatase activity (shown by phosphatase-deficient mutant) and is p53-dependent.","method":"Co-immunoprecipitation (EYA4-SIX2 interaction), phosphatase-deficient mutant analysis, knockdown, luciferase reporter assay, p53 epistasis","journal":"Advanced biotechnology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for interaction, mutagenesis of phosphatase, epistasis with p53; single lab, multiple orthogonal methods","pmids":["41991886"],"is_preprint":false}],"current_model":"SIX2 is a homeodomain transcription factor that cell-autonomously maintains nephron progenitor self-renewal by forming a regulatory complex with Lef/Tcf factors to suppress Wnt-directed differentiation; its activity is opposed by Notch signaling (which downregulates Six2 to permit differentiation), regulated by Eya1-mediated nuclear translocation and Brg1/SWI/SNF chromatin remodeling, and post-translationally controlled by ubiquitin-mediated degradation (via TRIM21 and TRIM25); it directly activates target genes including Gdnf, Pax9, Smurf1, LGSN, SPRED2, and METTL9 by binding their promoters or enhancers, and in cancer contexts promotes stemness partly through a SIX2/SOX2 axis and epigenetic silencing of E-cadherin via DNMT1-mediated promoter methylation."},"narrative":{"mechanistic_narrative":"SIX2 is a homeodomain transcription factor that cell-autonomously maintains multipotent nephron progenitor cells in a self-renewing, undifferentiated state by opposing the inductive Wnt9b/Wnt signal that drives mesenchymal-to-epithelial differentiation [PMID:18682239, PMID:17036046]. It enforces this balance by co-occupying cis-regulatory modules at differentiation genes (Wnt4, Fgf8) together with Lef/Tcf factors, forming a maintenance complex that is converted to a pro-differentiation complex when β-catenin enters it [PMID:22902740]; Osr1 acts synergistically downstream of SIX2 to reinforce this antagonism of Wnt-directed nephrogenesis [PMID:24598167]. SIX2 activity depends on its partner Eya1, which it translocates to the nucleus to control Myc, with loss of Eya1 collapsing SIX2 expression and the progenitor pool [PMID:25458011], and on the Brg1/SWI/SNF chromatin-remodeling complex, which SIX2 directs to enhancers of progenitor regulators such as Pbx1 and Mycn [PMID:34716243]. SIX2 binds DNA through its homeodomain and activates transcription via a C-terminal activation domain [PMID:15327782, PMID:19716816], directly activating target genes including its own promoter and Gdnf [PMID:15327782], and is positioned within developmental regulatory hierarchies as an output of Hox proteins (activated by Hox11, repressed by Hoxa2) [PMID:19716816, PMID:18321982] and a target whose downregulation by Notch signaling licenses differentiation [PMID:27633993]. SIX2 function is essential beyond the kidney, controlling pyloric sphincter and craniofacial/palate gene networks [PMID:19660448, PMID:29218017] and second heart field progenitor allocation [PMID:28122228]. SIX2 protein level is set post-translationally by competing ubiquitin-proteasome activities, with TRIM21 catalyzing K48-linked ubiquitination at K82/K89/K97 to drive degradation [PMID:40954199]. In cancer and disease contexts SIX2 promotes a stem-like state and metastasis, repressing E-cadherin and engaging a SIX2/SOX2 axis [PMID:25348955, PMID:30606720] and sustaining Wnt/β-catenin signaling [PMID:38554106]. A human SIX2 missense variant (p.Gly264Glu) destabilizes the protein and reduces activation of its target PAX9 [PMID:31765609].","teleology":[{"year":2004,"claim":"Established that SIX2 is a sequence-specific transcriptional activator with defined functional domains, answering how it acts on DNA.","evidence":"Promoter-reporter and DNA-binding assays plus domain mapping, identifying Gdnf and autoregulatory promoter sites and a C-terminal activation domain","pmids":["15327782"],"confidence":"Medium","gaps":["Genome-wide target repertoire not defined","Cofactor requirements for activation not established"]},{"year":2006,"claim":"Defined the core developmental function: SIX2 keeps metanephric mesenchyme progenitors undifferentiated against ureteric bud induction.","evidence":"Loss- and gain-of-function mouse genetics with organ culture showing premature/ectopic epithelial differentiation upon loss and blocked differentiation upon gain","pmids":["17036046"],"confidence":"High","gaps":["Molecular mechanism of differentiation suppression not yet defined","Direct target genes mediating maintenance unknown"]},{"year":2008,"claim":"Resolved that SIX2 acts cell-autonomously to self-renew a multipotent nephron progenitor population, and placed it in epistasis with the Wnt9b inductive signal.","evidence":"Genetic lineage tracing, clonal analysis, and conditional loss-of-function showing Six2-null cells ectopically join tubules via Wnt9b; separately, Hoxa2 control identified","pmids":["18682239","18321982"],"confidence":"High","gaps":["Direct transcriptional mechanism opposing Wnt not defined","Hox-to-Six2 regulatory element not yet mapped"]},{"year":2009,"claim":"Showed a single upstream enhancer integrates opposing Hox inputs and that SIX2 regulates non-renal organogenesis, broadening its developmental scope.","evidence":"In vivo enhancer dissection with Hox domain mutagenesis (Hox11 activation / Hoxa2 repression) and Six2-null analysis of pyloric sphincter gene networks","pmids":["19716816","19660448"],"confidence":"High","gaps":["How a shared site is read as activation vs repression in different tissues not fully resolved"]},{"year":2012,"claim":"Defined the molecular switch for self-renewal vs commitment: SIX2/Lef-Tcf maintenance complexes versus β-catenin-driven differentiation.","evidence":"ChIP, transcriptional profiling, and cis-regulatory mutagenesis showing SIX2 and β-catenin co-occupy Wnt4/Fgf8 modules","pmids":["22902740"],"confidence":"High","gaps":["Stoichiometry/structure of the SIX2-Lef/Tcf-β-catenin complex unknown","How β-catenin entry is triggered not defined"]},{"year":2014,"claim":"Identified the Eya1 and Osr1 partnerships that empower SIX2 activity and reinforce Wnt antagonism.","evidence":"Co-IP, conditional knockouts, phosphatase assays (Eya1/Myc), and TCF-Groucho interaction analysis (Osr1) with in vivo Wnt4 reporters","pmids":["25458011","24598167"],"confidence":"High","gaps":["How SIX2 mediates Eya1 nuclear import mechanistically unclear","Direct biochemical link between SIX2 and the Osr1-TCF-Groucho arm not established"]},{"year":2016,"claim":"Placed Notch upstream of SIX2 as the trigger that licenses differentiation, and identified LIF/STAT as a positive input sustaining SIX2.","evidence":"Notch conditional gain/loss-of-function with Six2 expression readout; STAT consensus-site reporter assays in metanephric mesenchyme","pmids":["27633993","26321142"],"confidence":"High","gaps":["Direct vs indirect Notch repression of Six2 not distinguished","STAT finding is Medium-confidence single-lab promoter assay"]},{"year":2017,"claim":"Refined dosage-dependent SIX2 control of progenitor proliferation vs self-renewal and extended its progenitor role to the second heart field and palate.","evidence":"Quantitative morphometry/EdU in Six2 heterozygotes; lineage tracing/Shh KO in cardiac progenitors; Hoxa2-Six2 epistasis with siRNA rescue in palate","pmids":["29217079","28122228","29218017"],"confidence":"Medium","gaps":["Mechanism coupling SIX2 dosage to MYC levels not resolved","Whether cardiac/palate roles share the kidney transcriptional mechanism unknown"]},{"year":2019,"claim":"Linked SIX2 to specific direct targets and to a human disease variant, and established a DNMT1-dependent epigenetic requirement in SIX2+ progenitors.","evidence":"ChIP/reporter assays mapping PAX9 and Gdnf/Smurf1 targets, p.Gly264Glu stability assay, and Six2-Cre conditional DNMT1 KO with WGBS/RNA-seq","pmids":["31765609","27148690","31720997","30850438"],"confidence":"Medium","gaps":["DNMT1 finding shows requirement in SIX2+ cells, not direct SIX2-DNMT1 interaction","Neuronal Gdnf/Smurf1 targets validated in single labs only"]},{"year":2014,"claim":"Established a pro-metastatic, stemness-promoting role for SIX2 in cancer via E-cadherin repression and a SIX2/SOX2 axis.","evidence":"Knockdown/overexpression, in vivo metastasis assays, promoter methylation analysis (Cdh1) and ChIP at the Sox2 Srr2 enhancer in breast cancer","pmids":["25348955","30606720"],"confidence":"Medium","gaps":["Mechanism by which SIX2 directs Cdh1 promoter methylation unresolved","Cancer findings from single labs"]},{"year":2021,"claim":"Defined SIX2's reliance on Brg1/SWI/SNF chromatin remodeling, its non-redundancy with the paralog Six1, and a conserved role in human β-cell maturation.","evidence":"Tagged-knock-in Co-IP and ChIP-seq (Brg1); Six1-for-Six2 knock-in rescue with comparative ChIP-seq; shRNA/ATAC-seq in human islets and SC-β cells","pmids":["34716243","35178390","33446570","32460030"],"confidence":"High","gaps":["How SIX2 selects loci that Six1 cannot occupy not defined","β-cell target gene mechanisms are Medium-confidence single-lab studies"]},{"year":2024,"claim":"Identified post-translational control of SIX2 abundance and new cancer/disease effector targets.","evidence":"TRIM25/TRIM21 Co-IP and site-mapped ubiquitination assays, NIK stabilization assays, and ChIP/CUT&Tag mapping of SPRED2, LGSN, PFN2, and METTL9 targets across cancer and neuronal models","pmids":["40954199","42105075","37461228","40523929","39256760","38554106"],"confidence":"Medium","gaps":["Whether these ubiquitin ligases regulate SIX2 in the developmental kidney context unknown","Most effector targets validated in single labs"]},{"year":2024,"claim":"Clarified a confounder in the widely used Six2TGC transgene by showing ectopic Six3 (not Six2) interferes with progenitor renewal.","evidence":"Targeted locus amplification, Hi-C, and CRISPR disruption with genetic rescue of the transgene","pmids":["38447671"],"confidence":"High","gaps":["Implications for reinterpreting prior Six2TGC-based data not systematically addressed"]},{"year":null,"claim":"How the SIX2 maintenance complex is structurally organized and how upstream signals (Notch, Wnt, growth factor inputs) are integrated to flip SIX2 between self-renewal and differentiation outputs remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of SIX2-Lef/Tcf-β-catenin complex","Direct molecular link between Notch signaling and Six2 promoter repression unmapped","Whether cancer/neuronal SIX2 mechanisms recapitulate the developmental transcriptional program untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[4,2,6,17,14,25]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[4,6,17,14]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[2,31]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,3,22]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[22]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,2,19,30]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[4,2,6,17]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,8,23]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[25,26,35]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[17,9,23]}],"complexes":["SIX2-Lef/Tcf maintenance complex","Brg1/SWI/SNF chromatin remodeling complex"],"partners":["EYA1","LEF1","TCF","CTNNB1","OSR1","SMARCA4","TRIM21","TRIM25"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NPC8","full_name":"Homeobox protein SIX2","aliases":["Sine oculis homeobox homolog 2"],"length_aa":291,"mass_kda":32.3,"function":"Transcription factor that plays an important role in the development of several organs, including kidney, skull and stomach. During kidney development, maintains cap mesenchyme multipotent nephron progenitor cells in an undifferentiated state by opposing the inductive signals emanating from the ureteric bud and cooperates with WNT9B to promote renewing progenitor cells proliferation. Acts through its interaction with TCF7L2 and OSR1 in a canonical Wnt signaling independent manner preventing transcription of differentiation genes in cap mesenchyme such as WNT4. Also acts independently of OSR1 to activate expression of many cap mesenchyme genes, including itself, GDNF and OSR1. During craniofacial development plays a role in growth and elongation of the cranial base through regulation of chondrocyte differentiation. During stomach organogenesis, controls pyloric sphincter formation and mucosal growth through regulation of a gene network including NKX2-5, BMPR1B, BMP4, SOX9 and GREM1. During branchial arch development, acts to mediate HOXA2 control over the insulin-like growth factor pathway. May also be involved in limb tendon and ligament development (By similarity). Plays a role in cell proliferation and migration","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9NPC8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SIX2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SIX2","total_profiled":1310},"omim":[{"mim_id":"618744","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 83; DEE83","url":"https://www.omim.org/entry/618744"},{"mim_id":"607375","title":"DOT1-LIKE; DOT1L","url":"https://www.omim.org/entry/607375"},{"mim_id":"606342","title":"SIX HOMEOBOX 4; SIX4","url":"https://www.omim.org/entry/606342"},{"mim_id":"606326","title":"SIX HOMEOBOX 6; SIX6","url":"https://www.omim.org/entry/606326"},{"mim_id":"604994","title":"SIX HOMEOBOX 2; SIX2","url":"https://www.omim.org/entry/604994"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"salivary gland","ntpm":19.9},{"tissue":"skeletal muscle","ntpm":32.0}],"url":"https://www.proteinatlas.org/search/SIX2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q9NPC8","domains":[{"cath_id":"1.10.10.60","chopping":"132-190","consensus_level":"high","plddt":95.0785,"start":132,"end":190},{"cath_id":"1.25.40","chopping":"10-113","consensus_level":"high","plddt":95.0283,"start":10,"end":113}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NPC8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NPC8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NPC8-F1-predicted_aligned_error_v6.png","plddt_mean":74.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SIX2","jax_strain_url":"https://www.jax.org/strain/search?query=SIX2"},"sequence":{"accession":"Q9NPC8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NPC8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NPC8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NPC8"}},"corpus_meta":[{"pmid":"18682239","id":"PMC_18682239","title":"Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development.","date":"2008","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/18682239","citation_count":763,"is_preprint":false},{"pmid":"17036046","id":"PMC_17036046","title":"Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17036046","citation_count":380,"is_preprint":false},{"pmid":"22902740","id":"PMC_22902740","title":"Six2 and Wnt regulate self-renewal and commitment of nephron progenitors through shared gene regulatory networks.","date":"2012","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/22902740","citation_count":214,"is_preprint":false},{"pmid":"25458011","id":"PMC_25458011","title":"Eya1 interacts with Six2 and Myc to regulate expansion of the nephron progenitor pool during nephrogenesis.","date":"2014","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/25458011","citation_count":99,"is_preprint":false},{"pmid":"15327782","id":"PMC_15327782","title":"The transcription factor Six2 activates expression of the Gdnf gene as well as its own promoter.","date":"2004","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/15327782","citation_count":87,"is_preprint":false},{"pmid":"24598167","id":"PMC_24598167","title":"Osr1 acts downstream of and interacts synergistically with Six2 to maintain nephron progenitor cells during kidney organogenesis.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24598167","citation_count":70,"is_preprint":false},{"pmid":"30832689","id":"PMC_30832689","title":"Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.","date":"2019","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30832689","citation_count":67,"is_preprint":false},{"pmid":"27633993","id":"PMC_27633993","title":"Notch signaling promotes nephrogenesis by downregulating Six2.","date":"2016","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27633993","citation_count":56,"is_preprint":false},{"pmid":"25348955","id":"PMC_25348955","title":"Homeoprotein Six2 promotes breast cancer metastasis via transcriptional and epigenetic control of E-cadherin expression.","date":"2014","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/25348955","citation_count":55,"is_preprint":false},{"pmid":"31962380","id":"PMC_31962380","title":"Circular RNA 0007255 regulates the progression of breast cancer through miR-335-5p/SIX2 axis.","date":"2020","source":"Thoracic cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31962380","citation_count":49,"is_preprint":false},{"pmid":"28122228","id":"PMC_28122228","title":"Temporally Distinct Six2-Positive Second Heart Field Progenitors Regulate Mammalian Heart Development and Disease.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28122228","citation_count":44,"is_preprint":false},{"pmid":"28435452","id":"PMC_28435452","title":"The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer.","date":"2017","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/28435452","citation_count":44,"is_preprint":false},{"pmid":"30905259","id":"PMC_30905259","title":"Crucial and Overlapping Roles of Six1 and Six2 in Craniofacial Development.","date":"2019","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/30905259","citation_count":41,"is_preprint":false},{"pmid":"31959818","id":"PMC_31959818","title":"The FGF, TGFβ and WNT axis Modulate Self-renewal of Human SIX2+ Urine Derived Renal Progenitor Cells.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31959818","citation_count":41,"is_preprint":false},{"pmid":"18321982","id":"PMC_18321982","title":"Six2 functions redundantly immediately downstream of Hoxa2.","date":"2008","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18321982","citation_count":41,"is_preprint":false},{"pmid":"30606720","id":"PMC_30606720","title":"SIX2 Mediates Late-Stage Metastasis via Direct Regulation of SOX2 and Induction of a Cancer Stem Cell Program.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30606720","citation_count":40,"is_preprint":false},{"pmid":"32460030","id":"PMC_32460030","title":"SIX2 Regulates Human β Cell Differentiation from Stem Cells and Functional Maturation In Vitro.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32460030","citation_count":38,"is_preprint":false},{"pmid":"22703800","id":"PMC_22703800","title":"SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor.","date":"2012","source":"Journal of pediatric surgery","url":"https://pubmed.ncbi.nlm.nih.gov/22703800","citation_count":38,"is_preprint":false},{"pmid":"33446570","id":"PMC_33446570","title":"SIX2 and SIX3 coordinately regulate functional maturity and fate of human pancreatic β cells.","date":"2021","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/33446570","citation_count":37,"is_preprint":false},{"pmid":"30850438","id":"PMC_30850438","title":"DNMT1 in Six2 Progenitor Cells Is Essential for Transposable Element Silencing and Kidney Development.","date":"2019","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/30850438","citation_count":36,"is_preprint":false},{"pmid":"20515681","id":"PMC_20515681","title":"Inactivation of Six2 in mouse identifies a novel genetic mechanism controlling development and growth of the cranial base.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20515681","citation_count":36,"is_preprint":false},{"pmid":"26321142","id":"PMC_26321142","title":"Preferential Propagation of Competent SIX2+ Nephronic Progenitors by LIF/ROCKi Treatment of the Metanephric Mesenchyme.","date":"2015","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26321142","citation_count":34,"is_preprint":false},{"pmid":"23499659","id":"PMC_23499659","title":"Wnt and BMP signaling cooperate with Hox in the control of Six2 expression in limb tendon precursor.","date":"2013","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23499659","citation_count":33,"is_preprint":false},{"pmid":"18570229","id":"PMC_18570229","title":"Misexpression of Six2 is associated with heritable frontonasal dysplasia and renal hypoplasia in 3H1 Br mice.","date":"2008","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/18570229","citation_count":33,"is_preprint":false},{"pmid":"29217079","id":"PMC_29217079","title":"Haploinsufficiency for the Six2 gene increases nephron progenitor proliferation promoting branching and nephron number.","date":"2017","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/29217079","citation_count":30,"is_preprint":false},{"pmid":"10773454","id":"PMC_10773454","title":"Structure, mapping and expression of the human gene encoding the homeodomain protein, SIX2.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10773454","citation_count":30,"is_preprint":false},{"pmid":"19716816","id":"PMC_19716816","title":"Non-homeodomain regions of Hox proteins mediate activation versus repression of Six2 via a single enhancer site in vivo.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19716816","citation_count":30,"is_preprint":false},{"pmid":"22912798","id":"PMC_22912798","title":"Conditional expression of Wnt9b in Six2-positive cells disrupts stomach and kidney function.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22912798","citation_count":29,"is_preprint":false},{"pmid":"29170429","id":"PMC_29170429","title":"Genome-wide meta-analysis in Japanese populations identifies novel variants at the TMC6-TMC8 and SIX3-SIX2 loci associated with HbA1c.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29170429","citation_count":28,"is_preprint":false},{"pmid":"19193724","id":"PMC_19193724","title":"Deficiency in Six2 during prenatal development is associated with reduced nephron number, chronic renal failure, and hypertension in Br/+ adult mice.","date":"2009","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19193724","citation_count":28,"is_preprint":false},{"pmid":"27212161","id":"PMC_27212161","title":"MicroRNA-185 inhibits cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Six2.","date":"2016","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27212161","citation_count":25,"is_preprint":false},{"pmid":"26581443","id":"PMC_26581443","title":"A new frontonasal dysplasia syndrome associated with deletion of the SIX2 gene.","date":"2015","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/26581443","citation_count":25,"is_preprint":false},{"pmid":"25500091","id":"PMC_25500091","title":"SIX2 Effects on Wilms Tumor Biology.","date":"2014","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25500091","citation_count":24,"is_preprint":false},{"pmid":"22995329","id":"PMC_22995329","title":"The pluripotent renal stem cell regulator SIX2 is activated in renal neoplasms and influences cellular proliferation and migration.","date":"2012","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22995329","citation_count":24,"is_preprint":false},{"pmid":"27148690","id":"PMC_27148690","title":"Transcription factor Six2 mediates the protection of GDNF on 6-OHDA lesioned dopaminergic neurons by regulating Smurf1 expression.","date":"2016","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/27148690","citation_count":24,"is_preprint":false},{"pmid":"19660448","id":"PMC_19660448","title":"Six2 activity is required for the formation of the mammalian pyloric sphincter.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19660448","citation_count":24,"is_preprint":false},{"pmid":"31012173","id":"PMC_31012173","title":"Six2 promotes non-small cell lung cancer cell stemness via transcriptionally and epigenetically regulating E-cadherin.","date":"2019","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/31012173","citation_count":22,"is_preprint":false},{"pmid":"24055707","id":"PMC_24055707","title":"MiR-181b targets Six2 and inhibits the proliferation of metanephric mesenchymal cells in vitro.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24055707","citation_count":22,"is_preprint":false},{"pmid":"29035842","id":"PMC_29035842","title":"Derivation and characterization of integration-free iPSC line ISRM-UM51 derived from SIX2-positive renal cells isolated from urine of an African male expressing the CYP2D6 *4/*17 variant which confers intermediate drug metabolizing activity.","date":"2017","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29035842","citation_count":22,"is_preprint":false},{"pmid":"20542577","id":"PMC_20542577","title":"Mutational analysis of HOXA2 and SIX2 in a Bronx population with isolated microtia.","date":"2010","source":"International journal of pediatric otorhinolaryngology","url":"https://pubmed.ncbi.nlm.nih.gov/20542577","citation_count":21,"is_preprint":false},{"pmid":"27509493","id":"PMC_27509493","title":"Zeb1 Is a Potential Regulator of Six2 in the Proliferation, Apoptosis and Migration of Metanephric Mesenchyme Cells.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27509493","citation_count":21,"is_preprint":false},{"pmid":"29218017","id":"PMC_29218017","title":"Six2 Plays an Intrinsic Role in Regulating Proliferation of Mesenchymal Cells in the Developing Palate.","date":"2017","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29218017","citation_count":18,"is_preprint":false},{"pmid":"38554106","id":"PMC_38554106","title":"SIX2 promotes cell plasticity via Wnt/β-catenin signalling in androgen receptor independent prostate cancer.","date":"2024","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/38554106","citation_count":16,"is_preprint":false},{"pmid":"27383657","id":"PMC_27383657","title":"SIX2 haploinsufficiency causes conductive hearing loss with ptosis in humans.","date":"2016","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27383657","citation_count":16,"is_preprint":false},{"pmid":"34716243","id":"PMC_34716243","title":"Chromatin Remodelers Interact with Eya1 and Six2 to Target Enhancers to Control Nephron Progenitor Cell Maintenance.","date":"2021","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/34716243","citation_count":15,"is_preprint":false},{"pmid":"31765609","id":"PMC_31765609","title":"Six2 regulates Pax9 expression, palatogenesis and craniofacial bone formation.","date":"2019","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/31765609","citation_count":14,"is_preprint":false},{"pmid":"35913414","id":"PMC_35913414","title":"De novo SIX2 activation in human kidneys treated with neonatal kidney stem/progenitor cells.","date":"2022","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/35913414","citation_count":13,"is_preprint":false},{"pmid":"25187057","id":"PMC_25187057","title":"miR181c promotes apoptosis and suppresses proliferation of metanephric mesenchyme cells by targeting Six2 in vitro.","date":"2014","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/25187057","citation_count":13,"is_preprint":false},{"pmid":"27144443","id":"PMC_27144443","title":"Postembryonic Nephrogenesis and Persistence of Six2-Expressing Nephron Progenitor Cells in the Reptilian Kidney.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27144443","citation_count":13,"is_preprint":false},{"pmid":"31090452","id":"PMC_31090452","title":"PPARG Negatively Modulates Six2 in Tumor Formation of Clear Cell Renal Cell Carcinoma.","date":"2019","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31090452","citation_count":12,"is_preprint":false},{"pmid":"29444177","id":"PMC_29444177","title":"Kidney-differentiated cells derived from Lowe Syndrome patient's iPSCs show ciliogenesis defects and Six2 retention at the Golgi complex.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29444177","citation_count":12,"is_preprint":false},{"pmid":"26009236","id":"PMC_26009236","title":"Identification of distal enhancers for Six2 expression in pronephros.","date":"2015","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26009236","citation_count":11,"is_preprint":false},{"pmid":"35178390","id":"PMC_35178390","title":"Six1 and Six2 of the Sine Oculis Homeobox Subfamily are Not Functionally Interchangeable in Mouse Nephron Formation.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35178390","citation_count":9,"is_preprint":false},{"pmid":"24573885","id":"PMC_24573885","title":"Down-regulated Six2 by knockdown of neurofibromin results in apoptosis of metanephric mesenchyme cells in vitro.","date":"2014","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24573885","citation_count":9,"is_preprint":false},{"pmid":"27618015","id":"PMC_27618015","title":"Six2 Is a Coordinator of LiCl-Induced Cell Proliferation and Apoptosis.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27618015","citation_count":8,"is_preprint":false},{"pmid":"29315086","id":"PMC_29315086","title":"SIX2 gene haploinsufficiency leads to a recognizable phenotype with ptosis, frontonasal dysplasia, and conductive hearing loss.","date":"2018","source":"Clinical dysmorphology","url":"https://pubmed.ncbi.nlm.nih.gov/29315086","citation_count":8,"is_preprint":false},{"pmid":"36522157","id":"PMC_36522157","title":"Tet2- and Tet3- Mediated Cytosine Hydroxymethylation in Six2 Progenitor Cells in Mice Is Critical for Nephron Progenitor Differentiation and Nephron Endowment.","date":"2022","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/36522157","citation_count":7,"is_preprint":false},{"pmid":"38447671","id":"PMC_38447671","title":"Reduced Nephron Endowment in Six2-TGCtg Mice Is Due to Six3 Misexpression by Aberrant Enhancer-Promoter Interactions in the Transgene.","date":"2024","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/38447671","citation_count":7,"is_preprint":false},{"pmid":"31720997","id":"PMC_31720997","title":"MES23.5 DA Immortalized Neuroblastoma Cells Self-protect Against Early Injury by Overexpressing Glial Cell-derived Neurotrophic Factor via Akt1/Eya1/Six2 Signaling.","date":"2019","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/31720997","citation_count":7,"is_preprint":false},{"pmid":"38688414","id":"PMC_38688414","title":"Microglial SIX2 suppresses lipopolysaccharide (LPS)-induced neuroinflammation by up-regulating FXYD2 expression.","date":"2024","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/38688414","citation_count":6,"is_preprint":false},{"pmid":"39556430","id":"PMC_39556430","title":"Six2 regulates the malignant progression and 5-FU resistance of hepatocellular carcinoma through the PI3K/AKT/mTOR pathway and DNMT1/E-cadherin methylation mechanism.","date":"2024","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/39556430","citation_count":6,"is_preprint":false},{"pmid":"32277572","id":"PMC_32277572","title":"Generation and characterization of Six2 conditional mice.","date":"2020","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/32277572","citation_count":4,"is_preprint":false},{"pmid":"39256760","id":"PMC_39256760","title":"The SIX2/PFN2 feedback loop promotes the stemness of gastric cancer cells.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39256760","citation_count":4,"is_preprint":false},{"pmid":"37461228","id":"PMC_37461228","title":"NIK-mediated reactivation of SIX2 enhanced the CSC-like traits of hepatocellular carcinoma cells through suppressing ubiquitin-proteasome system.","date":"2023","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/37461228","citation_count":4,"is_preprint":false},{"pmid":"34233203","id":"PMC_34233203","title":"Smarcd1 antagonizes the apoptosis of injured MES23.5 DA cells by enhancing the effect of Six2 on GDNF expression.","date":"2021","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/34233203","citation_count":4,"is_preprint":false},{"pmid":"31420918","id":"PMC_31420918","title":"Transcription factor Six2 induces a stem cell-like phenotype in renal cell carcinoma cells.","date":"2019","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/31420918","citation_count":3,"is_preprint":false},{"pmid":"28842839","id":"PMC_28842839","title":"Six2 is involved in GATA1-mediated cell apoptosis in mouse embryonic kidney-derived cell lines.","date":"2017","source":"In vitro cellular & developmental biology. Animal","url":"https://pubmed.ncbi.nlm.nih.gov/28842839","citation_count":3,"is_preprint":false},{"pmid":"37308406","id":"PMC_37308406","title":"[Effects of transcription factor SIX2 gene on the proliferation of bovine skeletal muscle satellite cells].","date":"2022","source":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","url":"https://pubmed.ncbi.nlm.nih.gov/37308406","citation_count":3,"is_preprint":false},{"pmid":"31191670","id":"PMC_31191670","title":"Constructing an Isogenic 3D Human Nephrogenic Progenitor Cell Model Composed of Endothelial, Mesenchymal, and SIX2-Positive Renal Progenitor Cells.","date":"2019","source":"Stem cells international","url":"https://pubmed.ncbi.nlm.nih.gov/31191670","citation_count":3,"is_preprint":false},{"pmid":"28420207","id":"PMC_28420207","title":"TβRII Regulates the Proliferation of Metanephric Mesenchyme Cells through Six2 In Vitro.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28420207","citation_count":3,"is_preprint":false},{"pmid":"24124738","id":"PMC_24124738","title":"[Expression and promoter methylation of SIX2 gene in peripheral blood of pediatric patients with nephroblastoma].","date":"2013","source":"Zhonghua yi xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/24124738","citation_count":2,"is_preprint":false},{"pmid":"30219227","id":"PMC_30219227","title":"Gulo regulates the proliferation, apoptosis and mesenchymal-to-epithelial transformation of metanephric mesenchyme cells via inhibiting Six2.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30219227","citation_count":2,"is_preprint":false},{"pmid":"21653879","id":"PMC_21653879","title":"Osmoregulatory defect in adult mice associated with deficient prenatal expression of six2.","date":"2011","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21653879","citation_count":2,"is_preprint":false},{"pmid":"40523929","id":"PMC_40523929","title":"Targeting SIX2 as a novel sensitization strategy of sorafenib treatment on advanced hepatocellular carcinoma through modulating METTL9-SLC7A11 axis.","date":"2025","source":"NPJ precision oncology","url":"https://pubmed.ncbi.nlm.nih.gov/40523929","citation_count":1,"is_preprint":false},{"pmid":"40954199","id":"PMC_40954199","title":"TRIM21-mediated ubiquitination of SIX2 attenuates breast cancer stemness via LGSN suppression.","date":"2025","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/40954199","citation_count":1,"is_preprint":false},{"pmid":"41168982","id":"PMC_41168982","title":"Human Urine-Derived SIX2-Positive Renal Progenitor Cells Partially Improve Kidney Fibrosis by Paracrine Signaling.","date":"2025","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/41168982","citation_count":1,"is_preprint":false},{"pmid":"37873415","id":"PMC_37873415","title":"Reduced nephron endowment in the common Six2-TGC  mouse line is due to Six3 misexpression by aberrant enhancer-promoter interactions in the transgene.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/37873415","citation_count":1,"is_preprint":false},{"pmid":"34109599","id":"PMC_34109599","title":"MicroRNA-185 inhibits cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Six2.","date":"2021","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34109599","citation_count":1,"is_preprint":false},{"pmid":"31651345","id":"PMC_31651345","title":"Correction to: Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.","date":"2019","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31651345","citation_count":1,"is_preprint":false},{"pmid":"41112069","id":"PMC_41112069","title":"OSR1 and SIX2 drive divergent transcriptional programs in human kidney cells: implications for regeneration and tumorigenesis.","date":"2025","source":"Frontiers in bioengineering and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/41112069","citation_count":0,"is_preprint":false},{"pmid":"41225540","id":"PMC_41225540","title":"Modelling APOL1-mediated kidney inflammation and fibrosis using a partially reprogrammed urine-derived SIX2-positive renal progenitor cell line.","date":"2025","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/41225540","citation_count":0,"is_preprint":false},{"pmid":"38804816","id":"PMC_38804816","title":"RETRACTION: Six2 Promotes Non-Small Cell Lung Cancer Cell Stemness Via Transcriptionally and Epigenetically Regulating E-Cadherin.","date":"2024","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/38804816","citation_count":0,"is_preprint":false},{"pmid":"41700504","id":"PMC_41700504","title":"SIX2-Mediated Microglial M2 Polarization and Exosomal miR-3470b Delivery Protect Dopaminergic Neurons in Parkinson's Disease.","date":"2026","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/41700504","citation_count":0,"is_preprint":false},{"pmid":"42105075","id":"PMC_42105075","title":"TRIM25 Suppresses Hippocampal Neuronal Autophagy under High Glucose via Ubiquitination and Degradation of SIX2.","date":"2026","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/42105075","citation_count":0,"is_preprint":false},{"pmid":"41991886","id":"PMC_41991886","title":"EYA4 promotes cellular senescence by enhancing P21 transcription through interaction with SIX2.","date":"2026","source":"Advanced biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/41991886","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.28.667124","title":"Modelling APOL1-mediated kidney inflammation and fibrosis using a partially reprogrammed urine derived SIX2-positive renal progenitor cell line","date":"2025-07-29","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.28.667124","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.02.662781","title":"Human Urine-derived SIX2-positive renal progenitor cells improve kidney injury in an IRI mouse model","date":"2025-07-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.02.662781","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.04.04.647241","title":"A Regulatory Axis for Tonotopic MYO7A Expression in Cochlear Hair Cells","date":"2025-04-05","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.04.647241","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.02.25.640014","title":"Lysine-specific demethylase 1a is obligatory for gene regulation during kidney development","date":"2025-02-26","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.25.640014","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.02.07.637033","title":"Dimethyl sulfoxide primes induced pluripotent stem cells for more efficient nephron progenitor and kidney organoid differentiation","date":"2025-02-08","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.07.637033","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46057,"output_tokens":8556,"usd":0.133255,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18485,"output_tokens":4764,"usd":0.105762,"stage2_stop_reason":"end_turn"},"total_usd":0.239017,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"Six2-expressing cap mesenchyme cells are a multipotent nephron progenitor population that self-renew throughout kidney development. Six2 functions cell-autonomously to maintain progenitor status: cap mesenchyme cells lacking Six2 activity ectopically contribute to nephron tubules via a Wnt9b inductive signal, demonstrating Six2's cell-autonomous role in suppressing differentiation.\",\n      \"method\": \"Genetic lineage tracing (pulse labeling), clonal analysis, conditional loss-of-function, organ culture\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal genetic methods (lineage tracing, clonal analysis, conditional KO) replicated across developmental stages; mechanistic epistasis with Wnt9b established\",\n      \"pmids\": [\"18682239\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Six2 is required to maintain the metanephric mesenchyme progenitor population in an undifferentiated state by opposing inductive signals from the ureteric bud. Functional inactivation of Six2 causes premature and ectopic mesenchymal-to-epithelial differentiation and depletion of progenitors. Gain of Six2 function in cortical mesenchymal cells is sufficient to prevent their epithelial differentiation.\",\n      \"method\": \"Loss-of-function mouse genetics (Six2 knockout), gain-of-function in organ culture assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal loss- and gain-of-function experiments with defined cellular phenotype, independently replicated\",\n      \"pmids\": [\"17036046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Six2 and β-catenin (Wnt signaling) co-occupy shared cis-regulatory modules flanking Wnt4 and Fgf8 in nephron progenitors. Six2 and Lef/Tcf factors form a regulatory complex that promotes progenitor maintenance, while entry of β-catenin into this complex promotes nephrogenesis. This regulatory balance controls commitment vs. self-renewal.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), transcriptional profiling, in vitro and in vivo reporter assays, mutagenesis of Lef/Tcf binding sites\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — ChIP, transcriptional profiling, cis-regulatory mutagenesis, and in vivo validation; multiple orthogonal methods in single study\",\n      \"pmids\": [\"22902740\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Eya1 interacts with Six2 (and Myc) to control self-renewing nephron progenitor cell activity. Six2 mediates translocation of Eya1 to the nucleus, where Eya1 uses its threonine phosphatase activity to control Myc phosphorylation/dephosphorylation. Conditional inactivation of Eya1 leads to loss of Six2 expression and premature epithelialization of progenitors.\",\n      \"method\": \"Co-immunoprecipitation, conditional knockout, cell fate tracing, biochemical phosphatase assay\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, conditional KO with defined phenotype, biochemical phosphatase assay; multiple orthogonal methods\",\n      \"pmids\": [\"25458011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Six2 activates expression of the Gdnf gene by binding to two Six2 binding sites in the Gdnf promoter. Six2 also binds and activates its own promoter (autoregulation). Six2 possesses a transcriptional activation domain in the C-terminus and nuclear localization determinants in the Six domain.\",\n      \"method\": \"Promoter-reporter assay, DNA binding assay (identification of promoter binding sites), transgenic LacZ reporter mice, biochemical characterization of Six2 protein domains\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assays with identified binding sites and domain mapping; single lab, two orthogonal methods\",\n      \"pmids\": [\"15327782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Osr1 acts downstream of Six2 (Six2 is required to maintain Osr1 expression in undifferentiated cap mesenchyme) and both act synergistically to prevent premature nephron progenitor differentiation. Osr1, but not Six2, enhances TCF interaction with Groucho co-repressors to antagonize Wnt/β-catenin-directed nephrogenic differentiation.\",\n      \"method\": \"Conditional knockout (tissue-specific), epistasis analysis, protein interaction assay (TCF-Groucho complex), in vivo Wnt4 enhancer reporter\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with defined phenotype, epistasis between Six2 and Osr1, protein interaction (TCF-Groucho), in vivo reporter; multiple orthogonal methods\",\n      \"pmids\": [\"24598167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A single enhancer site upstream of the Six2 coding sequence is responsible for both activation by Hox11 proteins in the kidney and repression by Hoxa2 in the branchial arch and facial mesenchyme. DNA-binding activity is required for both activation and repression, but protein domains N- and C-terminal to the homeodomain confer activation versus repression activity.\",\n      \"method\": \"In vivo enhancer analysis in transgenic mice, mutagenesis of Hox protein domains, loss-of-function genetics\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vivo enhancer dissection with domain mutagenesis, both activation and repression mechanisms established in single study\",\n      \"pmids\": [\"19716816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Six2 is a direct downstream transcriptional target of Hoxa2 in vivo. Ectopic expression of Six2 in the absence of Hoxa2 contributes to the Hoxa2 mouse mutant phenotype, and Six2 acts to mediate Hoxa2 control over the insulin-like growth factor pathway during branchial arch development.\",\n      \"method\": \"Genetic epistasis, in vivo target gene identification, loss-of-function (Hoxa2 knockout)\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis in vivo, direct downstream target demonstrated with rescue experiments\",\n      \"pmids\": [\"18321982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Notch signaling is necessary and sufficient for downregulation of Six2 during nephrogenesis. Loss of Notch signaling in nephron progenitors prevents Six2 downregulation and blocks differentiation into any nephron segment, placing Notch upstream of Six2 in the differentiation pathway.\",\n      \"method\": \"Conditional gain- and loss-of-function of Notch signaling in mice, analysis of Six2 expression\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal gain/loss-of-function, defined cellular phenotype, pathway epistasis established\",\n      \"pmids\": [\"27633993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Six2 promotes breast cancer metastasis by transcriptionally and epigenetically repressing E-cadherin. Mechanistically, Six2 upregulates Zeb2 (in part through a microRNA-mediated mechanism) and stimulates promoter methylation of the E-cadherin gene (Cdh1). E-cadherin downregulation is necessary for Six2's ability to increase soft agar growth and in vivo metastasis.\",\n      \"method\": \"Loss-of-function (knockdown), gain-of-function (overexpression), in vivo metastasis assay, promoter methylation analysis, epistasis rescue\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo metastasis model, promoter methylation, epistasis; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"25348955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Six2 directly binds the Sox2 Srr2 enhancer, promoting Sox2 expression and downstream expression of Nanog in breast cancer cells, thereby enhancing cancer stem cell properties and metastatic colonization.\",\n      \"method\": \"ChIP (direct enhancer binding), knockdown/overexpression functional assays, in vivo metastasis models\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct binding, multiple functional assays; single lab\",\n      \"pmids\": [\"30606720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Eya1 and Six2 interact with the Brg1-based SWI/SNF chromatin remodeling complex during kidney development. Brg1 occupies a distal enhancer of Eya1 driving nephron progenitor-specific expression. Brg1 enrichment to distal intronic enhancers of Pbx1 and a proximal promoter of Mycn requires Six2 activity.\",\n      \"method\": \"Co-immunoprecipitation (tagged knock-in), conditional knockout, genome-wide ChIP-seq, transcriptome profiling, in vivo enhancer reporter assay\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP with tagged knock-in, genome-wide binding analysis, conditional KO with transcriptome profiling, in vivo reporters; multiple orthogonal methods\",\n      \"pmids\": [\"34716243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SIX2 regulates functional maturation of human SC-β cells; knockdown or knockout of SIX2 drastically limits glucose-stimulated insulin secretion, cytoplasmic calcium flux, and mitochondrial respiration, and regulates expression of genes associated with these β cell processes.\",\n      \"method\": \"Knockdown (KD) and knockout (KO) in hESC-derived β cells, static and dynamic insulin secretion assays, calcium imaging, mitochondrial respiration assay, transcriptome analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD and KO with multiple functional readouts; single lab, orthogonal assays\",\n      \"pmids\": [\"32460030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SIX2 and SIX3 regulate distinct gene targets in human β cells: SIX2 loss markedly impairs expression of genes governing β-cell insulin processing, glucose sensing, and electrophysiology. Chromatin accessibility studies identified genes directly regulated by SIX2.\",\n      \"method\": \"shRNA knockdown in human adult islets, transcriptome analysis, chromatin accessibility (ATAC-seq)\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — shRNA in native human islets, transcriptome + chromatin accessibility; single lab, two orthogonal methods\",\n      \"pmids\": [\"33446570\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Six2 mediates the neuroprotective effect of GDNF on dopaminergic neurons by directly binding to the CAGCTG sequence of the Smurf1 promoter and promoting Smurf1 expression, which in turn decreases p53 expression to reduce apoptosis.\",\n      \"method\": \"ChIP-seq, ChIP-qPCR, knockdown/overexpression, in vitro and in vivo apoptosis assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq for genome-wide binding plus ChIP-qPCR validation, functional rescue; single lab\",\n      \"pmids\": [\"27148690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Six2 activates the GDNF promoter by directly binding to it in dopaminergic cells, and this activation is regulated by the Akt1/Eya1/Six2 signaling axis: Akt1 phosphorylates Eya1, activated Eya1 decreases Six2 phosphorylation, and dephosphorylated Six2 promotes GDNF transcription.\",\n      \"method\": \"ChIP-qPCR (direct promoter binding), phosphorylation analysis, knockdown/overexpression\",\n      \"journal\": \"Journal of molecular neuroscience : MN\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-qPCR for direct binding, kinase cascade analysis; single lab, two orthogonal methods\",\n      \"pmids\": [\"31720997\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"LIF activates STAT, which binds to a STAT consensus sequence in the Six2 proximal promoter to sustain SIX2 levels in metanephric mesenchyme cells, maintaining the SIX2+ progenitor pool.\",\n      \"method\": \"Promoter-reporter assay, STAT binding site identification, LIF stimulation experiments, in vitro culture model\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — STAT binding site in Six2 promoter identified and functionally tested; single lab\",\n      \"pmids\": [\"26321142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Six2 directly binds to the PAX9 5' upstream regulatory element and activates PAX9 expression; a human SIX2 coding missense variant (p.Gly264Glu) affects SIX2 protein stability and leads to decreased PAX9 expression.\",\n      \"method\": \"ChIP (SIX2 binding to PAX9 enhancer), luciferase reporter assay, mutagenesis (variant functional analysis), protein stability assay\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP binding, reporter assay, variant functional analysis; single lab, two orthogonal methods\",\n      \"pmids\": [\"31765609\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In the developing kidney, Six2-dependent progenitor proliferation and self-renewal are separable by gene dosage: Six2 heterozygotes show increased nephron progenitor proliferation with increased MYC protein and MYC target gene upregulation, despite reduced SIX2 levels.\",\n      \"method\": \"Quantitative morphometry, EdU labeling (proliferation), immunostaining (MYC protein), transcriptional profiling\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative proliferation assay, molecular marker analysis; single lab, multiple readouts\",\n      \"pmids\": [\"29217079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Six2 activity is required for the formation of the pyloric sphincter, regulating a gene network including Bmp4, Bmpr1b, Nkx2.5, Sox9, and Gremlin in mice.\",\n      \"method\": \"Loss-of-function genetics (Six2 null mice), expression analysis of target genes\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined phenotype in KO mouse, expression of downstream genes; single lab\",\n      \"pmids\": [\"19660448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Smarcd1 (a SWI/SNF chromatin-remodeling complex member) forms a transcription complex with Six2 in dopaminergic neurons and is recruited to the GDNF promoter (specifically the 2840–2933 bp region) by Six2 to enhance Six2-driven GDNF expression and protect against apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, ChIP (Smarcd1 binding to GDNF promoter region), knockdown/overexpression functional assays, LC-ESI-MS (interactome screen)\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and ChIP for direct complex and promoter binding; single lab, two orthogonal methods\",\n      \"pmids\": [\"34233203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Six2 functions downstream of Hoxa2 in palate development: Six2 mRNA and protein are upregulated in Hoxa2-null palatal shelves, and siRNA-mediated Six2 knockdown restores proliferation and Cyclin D1 expression in Hoxa2-null palatal mesenchyme cells to near wild-type levels.\",\n      \"method\": \"Conditional loss-of-function (Hoxa2 KO), siRNA knockdown, cell proliferation assay (Ki-67 immunostaining, in vitro proliferation), western blot\",\n      \"journal\": \"Frontiers in physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis between Hoxa2 and Six2 confirmed by siRNA rescue; single lab, two orthogonal methods\",\n      \"pmids\": [\"29218017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In Lowe syndrome (OCRL1 mutation), the transcription factor Six2 is substantially retained in the Golgi complex in kidney-differentiated cells, with reduced nuclear-localized fraction; OCRL1 knockout reproduces both ciliogenesis defects and Six2 retention at the Golgi.\",\n      \"method\": \"iPSC differentiation to kidney cells, immunofluorescence (subcellular fractionation/localization), OCRL1 KO in HK2 cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct subcellular localization with functional consequence (reduced nuclear fraction); confirmed in multiple cell systems\",\n      \"pmids\": [\"29444177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SIX2 depletion in androgen-independent prostate cancer cells induces a switch from stem-like to epithelial state, reducing proliferation, colony formation, and metastasis both in vitro and in vivo. These effects are mediated through downregulation of the Wnt/β-catenin signaling pathway and reduction of nuclear β-catenin.\",\n      \"method\": \"Knockdown (siRNA/shRNA), chromatin accessibility analysis, in vitro and in vivo functional assays, immunostaining for nuclear β-catenin\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD with defined phenotype in vitro and in vivo, chromatin landscape analysis; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"38554106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SIX2 directly regulates METTL9 expression (shown by CUT&Tag analysis). METTL9 binds to SLC7A11 (confirmed by Co-IP), enhancing SLC7A11 stability and reducing degradation, thereby regulating ferroptosis independently of the GPX4 pathway.\",\n      \"method\": \"CUT&Tag (direct binding), Co-immunoprecipitation (METTL9-SLC7A11 interaction), RNA sequencing, overexpression/knockdown functional assays\",\n      \"journal\": \"NPJ precision oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CUT&Tag for direct binding, Co-IP for protein interaction; single lab, two orthogonal methods\",\n      \"pmids\": [\"40523929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TRIM21 acts as an E3 ubiquitin ligase for SIX2: TRIM21 binds to SIX2 via its PRY-SPRY domain and catalyzes K48-type ubiquitination at lysine residues K82, K89, and K97 of SIX2, promoting its degradation via the ubiquitin-proteasome pathway. SIX2 transcriptionally activates LGSN expression through direct binding to its promoter.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay (K48-type), site-directed mutagenesis (K82/K89/K97), ChIP (SIX2 binding to LGSN promoter), proteasome inhibition (MG132)\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — Co-IP, site-directed mutagenesis of ubiquitination sites, ChIP for direct promoter binding; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"40954199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NIK (NF-κB Inducing Kinase) promotes SIX2 protein stability by suppressing its ubiquitination via the ubiquitin-proteasome system: NIK knockdown promotes SIX2 ubiquitination and decreases its protein stability (rescued by MG132 proteasome inhibitor), without affecting SIX2 mRNA levels.\",\n      \"method\": \"Knockdown, ubiquitination assay, MG132 proteasome inhibitor rescue, protein stability assay\",\n      \"journal\": \"Environmental toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ubiquitination assay, proteasome inhibitor rescue; single lab, two orthogonal methods\",\n      \"pmids\": [\"37461228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SIX2 directly binds the PFN2 promoter to activate PFN2 expression. In turn, PFN2 promotes mRNA stability of SIX2 by recruiting the RNA binding protein YBX-1, activating the MAPK/JNK pathway downstream.\",\n      \"method\": \"ChIP (SIX2 binding to PFN2 promoter), RNA stability assay, Co-immunoprecipitation (PFN2-YBX-1), JNK pathway inhibition\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, RNA stability assay, Co-IP; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"39256760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Aberrant enhancer-promoter interactions in the Six2TGC transgene drive ectopic expression of Six3 (not Six2), which interferes with SIX2 function in nephron progenitor cell renewal through its C-terminal domain, causing reduced nephron endowment.\",\n      \"method\": \"Targeted locus amplification (integration site mapping), Hi-C (chromatin conformation capture), CRISPR disruption of Six3 within transgene, genetic rescue experiments\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — Hi-C chromatin conformation, CRISPR disruption with rescue, multiple genetic approaches in single study\",\n      \"pmids\": [\"38447671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DNMT1 is required in Six2-positive nephron progenitor cells for silencing of transposable elements and embryonic non-renal lineage genes; loss of DNMT1 (but not DNMT3a, DNMT3b, or TET2) in Six2-positive cells leads to severe kidney developmental defects with endogenous retroviral transcript activation and cell death.\",\n      \"method\": \"Conditional knockout (Six2-Cre driver), genome-wide methylation analysis (WGBS), RNA-seq, comparison with DNMT3a/3b/TET2 conditional KOs\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with genome-wide molecular profiling and systematic comparison among multiple epigenetic enzymes; single lab but comprehensive\",\n      \"pmids\": [\"30850438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Six2 marks a dynamic subset of second heart field progenitors whose descendants are allocated successively to regions of the heart. Six2 expression in cardiac progenitors depends in part on Shh signaling, and Shh deletion results in severe deficiency of Six2-positive progenitors.\",\n      \"method\": \"Genetic lineage tracing, progenitor ablation, conditional knockout of Shh, immunostaining\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — lineage tracing and genetic ablation with defined phenotype; single lab\",\n      \"pmids\": [\"28122228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Six1 cannot substitute for Six2 in mouse nephron progenitor renewal: forced Six1 expression mediated Eya1 nuclear translocation and inhibited premature epithelialization, but failed to rescue proliferation defects and cell death caused by Six2 knockout. Genome-wide binding showed Six1 occupied only a subset of Six2 target sites, with many Six2-bound loci crucial to progenitor renewal lacking Six1 occupancy.\",\n      \"method\": \"Conditional knock-in (Six1 replacing Six2), genome-wide ChIP-seq (Six1 vs. Six2 binding), phenotypic rescue analysis\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide binding comparison, conditional knock-in rescue experiment; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"35178390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Smad3 can transcriptionally target Six2 (identified by bioinformatics and validated by luciferase assay). TβRII promotes Six2 expression through Smad3-mediated transcriptional regulation; Six2 partially rescues proliferation defects caused by TβRII knockdown in metanephric mesenchyme cells.\",\n      \"method\": \"Luciferase reporter assay (Smad3 targeting Six2 promoter), knockdown/overexpression, EdU proliferation assay\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — luciferase assay and functional rescue; single lab, limited orthogonal validation\",\n      \"pmids\": [\"28420207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Zeb1 promotes Six2 promoter reporter activity (luciferase assay) and its expression in metanephric mesenchyme cells; knockdown of Zeb1 decreases Six2 expression and reduces cell proliferation and migration.\",\n      \"method\": \"Dual-luciferase reporter assay, knockdown, western blot, RT-PCR, EdU assay\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — luciferase assay plus expression analysis; single lab, single method for transcriptional regulation\",\n      \"pmids\": [\"27509493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GATA1 directly binds the Six2 promoter and promotes its transcriptional activity; mutation of GATA1 binding sites in the mSix2 promoter decreases promoter activity. Knockdown of GATA1 reduces Six2 expression and increases apoptosis in metanephric mesenchyme cells, which is rescued by Six2 overexpression.\",\n      \"method\": \"Luciferase reporter assay with GATA1 binding site mutagenesis, knockdown, qPCR, apoptosis assay, rescue experiment\",\n      \"journal\": \"In vitro cellular & developmental biology. Animal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — luciferase assay with site mutagenesis, functional rescue; single lab\",\n      \"pmids\": [\"28842839\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TRIM25 directly interacts with SIX2 and promotes its ubiquitination and degradation; TRIM25 reduces SPRED2 transcription (via SIX2 degradation), leading to ERK phosphorylation and suppression of neuronal autophagy under high-glucose conditions. SIX2 transcriptionally activates SPRED2 expression.\",\n      \"method\": \"Co-immunoprecipitation, cycloheximide chase assay, ubiquitination assay, ChIP, dual-luciferase reporter, western blot\",\n      \"journal\": \"Journal of molecular neuroscience : MN\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ubiquitination assay, protein stability assay, ChIP; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"42105075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"EYA4 interacts with SIX2 to promote p21 expression and accelerate cellular senescence. This regulatory function is independent of EYA4's phosphatase activity (shown by phosphatase-deficient mutant) and is p53-dependent.\",\n      \"method\": \"Co-immunoprecipitation (EYA4-SIX2 interaction), phosphatase-deficient mutant analysis, knockdown, luciferase reporter assay, p53 epistasis\",\n      \"journal\": \"Advanced biotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for interaction, mutagenesis of phosphatase, epistasis with p53; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"41991886\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SIX2 is a homeodomain transcription factor that cell-autonomously maintains nephron progenitor self-renewal by forming a regulatory complex with Lef/Tcf factors to suppress Wnt-directed differentiation; its activity is opposed by Notch signaling (which downregulates Six2 to permit differentiation), regulated by Eya1-mediated nuclear translocation and Brg1/SWI/SNF chromatin remodeling, and post-translationally controlled by ubiquitin-mediated degradation (via TRIM21 and TRIM25); it directly activates target genes including Gdnf, Pax9, Smurf1, LGSN, SPRED2, and METTL9 by binding their promoters or enhancers, and in cancer contexts promotes stemness partly through a SIX2/SOX2 axis and epigenetic silencing of E-cadherin via DNMT1-mediated promoter methylation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SIX2 is a homeodomain transcription factor that cell-autonomously maintains multipotent nephron progenitor cells in a self-renewing, undifferentiated state by opposing the inductive Wnt9b/Wnt signal that drives mesenchymal-to-epithelial differentiation [#0, #1]. It enforces this balance by co-occupying cis-regulatory modules at differentiation genes (Wnt4, Fgf8) together with Lef/Tcf factors, forming a maintenance complex that is converted to a pro-differentiation complex when \\u03b2-catenin enters it [#2]; Osr1 acts synergistically downstream of SIX2 to reinforce this antagonism of Wnt-directed nephrogenesis [#5]. SIX2 activity depends on its partner Eya1, which it translocates to the nucleus to control Myc, with loss of Eya1 collapsing SIX2 expression and the progenitor pool [#3], and on the Brg1/SWI/SNF chromatin-remodeling complex, which SIX2 directs to enhancers of progenitor regulators such as Pbx1 and Mycn [#11]. SIX2 binds DNA through its homeodomain and activates transcription via a C-terminal activation domain [#4, #6], directly activating target genes including its own promoter and Gdnf [#4], and is positioned within developmental regulatory hierarchies as an output of Hox proteins (activated by Hox11, repressed by Hoxa2) [#6, #7] and a target whose downregulation by Notch signaling licenses differentiation [#8]. SIX2 function is essential beyond the kidney, controlling pyloric sphincter and craniofacial/palate gene networks [#19, #21] and second heart field progenitor allocation [#30]. SIX2 protein level is set post-translationally by competing ubiquitin-proteasome activities, with TRIM21 catalyzing K48-linked ubiquitination at K82/K89/K97 to drive degradation [#25]. In cancer and disease contexts SIX2 promotes a stem-like state and metastasis, repressing E-cadherin and engaging a SIX2/SOX2 axis [#9, #10] and sustaining Wnt/\\u03b2-catenin signaling [#23]. A human SIX2 missense variant (p.Gly264Glu) destabilizes the protein and reduces activation of its target PAX9 [#17].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established that SIX2 is a sequence-specific transcriptional activator with defined functional domains, answering how it acts on DNA.\",\n      \"evidence\": \"Promoter-reporter and DNA-binding assays plus domain mapping, identifying Gdnf and autoregulatory promoter sites and a C-terminal activation domain\",\n      \"pmids\": [\"15327782\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Genome-wide target repertoire not defined\", \"Cofactor requirements for activation not established\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined the core developmental function: SIX2 keeps metanephric mesenchyme progenitors undifferentiated against ureteric bud induction.\",\n      \"evidence\": \"Loss- and gain-of-function mouse genetics with organ culture showing premature/ectopic epithelial differentiation upon loss and blocked differentiation upon gain\",\n      \"pmids\": [\"17036046\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of differentiation suppression not yet defined\", \"Direct target genes mediating maintenance unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Resolved that SIX2 acts cell-autonomously to self-renew a multipotent nephron progenitor population, and placed it in epistasis with the Wnt9b inductive signal.\",\n      \"evidence\": \"Genetic lineage tracing, clonal analysis, and conditional loss-of-function showing Six2-null cells ectopically join tubules via Wnt9b; separately, Hoxa2 control identified\",\n      \"pmids\": [\"18682239\", \"18321982\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional mechanism opposing Wnt not defined\", \"Hox-to-Six2 regulatory element not yet mapped\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed a single upstream enhancer integrates opposing Hox inputs and that SIX2 regulates non-renal organogenesis, broadening its developmental scope.\",\n      \"evidence\": \"In vivo enhancer dissection with Hox domain mutagenesis (Hox11 activation / Hoxa2 repression) and Six2-null analysis of pyloric sphincter gene networks\",\n      \"pmids\": [\"19716816\", \"19660448\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a shared site is read as activation vs repression in different tissues not fully resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined the molecular switch for self-renewal vs commitment: SIX2/Lef-Tcf maintenance complexes versus \\u03b2-catenin-driven differentiation.\",\n      \"evidence\": \"ChIP, transcriptional profiling, and cis-regulatory mutagenesis showing SIX2 and \\u03b2-catenin co-occupy Wnt4/Fgf8 modules\",\n      \"pmids\": [\"22902740\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry/structure of the SIX2-Lef/Tcf-\\u03b2-catenin complex unknown\", \"How \\u03b2-catenin entry is triggered not defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified the Eya1 and Osr1 partnerships that empower SIX2 activity and reinforce Wnt antagonism.\",\n      \"evidence\": \"Co-IP, conditional knockouts, phosphatase assays (Eya1/Myc), and TCF-Groucho interaction analysis (Osr1) with in vivo Wnt4 reporters\",\n      \"pmids\": [\"25458011\", \"24598167\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How SIX2 mediates Eya1 nuclear import mechanistically unclear\", \"Direct biochemical link between SIX2 and the Osr1-TCF-Groucho arm not established\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Placed Notch upstream of SIX2 as the trigger that licenses differentiation, and identified LIF/STAT as a positive input sustaining SIX2.\",\n      \"evidence\": \"Notch conditional gain/loss-of-function with Six2 expression readout; STAT consensus-site reporter assays in metanephric mesenchyme\",\n      \"pmids\": [\"27633993\", \"26321142\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect Notch repression of Six2 not distinguished\", \"STAT finding is Medium-confidence single-lab promoter assay\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Refined dosage-dependent SIX2 control of progenitor proliferation vs self-renewal and extended its progenitor role to the second heart field and palate.\",\n      \"evidence\": \"Quantitative morphometry/EdU in Six2 heterozygotes; lineage tracing/Shh KO in cardiac progenitors; Hoxa2-Six2 epistasis with siRNA rescue in palate\",\n      \"pmids\": [\"29217079\", \"28122228\", \"29218017\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism coupling SIX2 dosage to MYC levels not resolved\", \"Whether cardiac/palate roles share the kidney transcriptional mechanism unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linked SIX2 to specific direct targets and to a human disease variant, and established a DNMT1-dependent epigenetic requirement in SIX2+ progenitors.\",\n      \"evidence\": \"ChIP/reporter assays mapping PAX9 and Gdnf/Smurf1 targets, p.Gly264Glu stability assay, and Six2-Cre conditional DNMT1 KO with WGBS/RNA-seq\",\n      \"pmids\": [\"31765609\", \"27148690\", \"31720997\", \"30850438\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"DNMT1 finding shows requirement in SIX2+ cells, not direct SIX2-DNMT1 interaction\", \"Neuronal Gdnf/Smurf1 targets validated in single labs only\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established a pro-metastatic, stemness-promoting role for SIX2 in cancer via E-cadherin repression and a SIX2/SOX2 axis.\",\n      \"evidence\": \"Knockdown/overexpression, in vivo metastasis assays, promoter methylation analysis (Cdh1) and ChIP at the Sox2 Srr2 enhancer in breast cancer\",\n      \"pmids\": [\"25348955\", \"30606720\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which SIX2 directs Cdh1 promoter methylation unresolved\", \"Cancer findings from single labs\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined SIX2's reliance on Brg1/SWI/SNF chromatin remodeling, its non-redundancy with the paralog Six1, and a conserved role in human \\u03b2-cell maturation.\",\n      \"evidence\": \"Tagged-knock-in Co-IP and ChIP-seq (Brg1); Six1-for-Six2 knock-in rescue with comparative ChIP-seq; shRNA/ATAC-seq in human islets and SC-\\u03b2 cells\",\n      \"pmids\": [\"34716243\", \"35178390\", \"33446570\", \"32460030\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How SIX2 selects loci that Six1 cannot occupy not defined\", \"\\u03b2-cell target gene mechanisms are Medium-confidence single-lab studies\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified post-translational control of SIX2 abundance and new cancer/disease effector targets.\",\n      \"evidence\": \"TRIM25/TRIM21 Co-IP and site-mapped ubiquitination assays, NIK stabilization assays, and ChIP/CUT&Tag mapping of SPRED2, LGSN, PFN2, and METTL9 targets across cancer and neuronal models\",\n      \"pmids\": [\"40954199\", \"42105075\", \"37461228\", \"40523929\", \"39256760\", \"38554106\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether these ubiquitin ligases regulate SIX2 in the developmental kidney context unknown\", \"Most effector targets validated in single labs\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Clarified a confounder in the widely used Six2TGC transgene by showing ectopic Six3 (not Six2) interferes with progenitor renewal.\",\n      \"evidence\": \"Targeted locus amplification, Hi-C, and CRISPR disruption with genetic rescue of the transgene\",\n      \"pmids\": [\"38447671\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Implications for reinterpreting prior Six2TGC-based data not systematically addressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the SIX2 maintenance complex is structurally organized and how upstream signals (Notch, Wnt, growth factor inputs) are integrated to flip SIX2 between self-renewal and differentiation outputs remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of SIX2-Lef/Tcf-\\u03b2-catenin complex\", \"Direct molecular link between Notch signaling and Six2 promoter repression unmapped\", \"Whether cancer/neuronal SIX2 mechanisms recapitulate the developmental transcriptional program untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [4, 2, 6, 17, 14, 25]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [4, 6, 17, 14]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [2, 31]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 3, 22]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 2, 19, 30]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [4, 2, 6, 17]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 8, 23]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [25, 26, 35]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [17, 9, 23]}\n    ],\n    \"complexes\": [\"SIX2-Lef/Tcf maintenance complex\", \"Brg1/SWI/SNF chromatin remodeling complex\"],\n    \"partners\": [\"EYA1\", \"LEF1\", \"TCF\", \"CTNNB1\", \"OSR1\", \"SMARCA4\", \"TRIM21\", \"TRIM25\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}